Sanofi-Aventis Appoints Euro RSCG Worldwide, Part of the Havas Group, as one of its two Strategic Communication Partners, and no
2006年11月17日 - 2:47AM
PRニュース・ワイアー (英語)
Euro RSCG Will Manage all Communication Activity for New Diabetes
and Thrombosis Therapy Brands Through its Euro RSCG Life Global
Healthcare Agency Group PARIS, November 16 /PRNewswire-FirstCall/
-- Sanofi-Aventis, a leading pharmaceutical company headquartered
in France, has confirmed Euro RSCG Life as the global agency in
charge of all communications for Lovenox/Clexane, the no 1 product
for thrombosis treatment, and for Lantus and Apidra, market leading
diabetes treatments. Sanofi-Aventis has also amplified its
partnership with Euro RSCG Life by awarding the agency the
responsibility of launching all communications programs for all new
brands in these two therapeutic domains. Sanofi-Aventis has also
awarded Euro RSCG C&O their Corporate Communications account,
including internal editorial programs and publications. The Havas
Group emphasizes that this success is the fruit of real
international collaboration with all Euro RSCG Worldwide's teams in
more than 40 countries. Sanofi-Aventis is Euro RSCG Worldwide's
first global pharmaceutical client and this appointment
demonstrates a significant increase in activity across the broad
range of skills offered by Euro RSCG Worldwide- advertising,
corporate communications, media relations, medical communication
and interactive communication. About Havas Havas (Euronext Paris:
HAV.PA) is a global advertising and communications services group.
Headquartered in Paris, Havas operates through its two worldwide
networks, Euro RSCG Worldwide headquartered in New York and Havas
Media in Barcelona, and through Arnold Worldwide Partners. A
multicultural and decentralized Group, Havas is present in more
than 75 countries through its networks of agencies and contractual
affiliations. The Group offers a broad range of communications
services, including traditional advertising, direct marketing,
media planning and buying, corporate communications, sales
promotion, design, human resources, sports marketing, multimedia
interactive communications and public relations. Havas employs
approximately 14,400 people. Further information about Havas is
available on the company's website: http://www.havas.com/ About
Sanofi-Aventis The Sanofi-aventis Group is the world's 3rd largest
pharmaceutical company, ranking number 1 in Europe. Backed by a
world-class R&D organization, Sanofi-Aventis is developing
leading positions in seven major therapeutic areas: cardiovascular
disease, thrombosis, oncology, diabetes, central nervous system,
internal medicine, vaccines. Contacts: Havas: Anne Marsan Tel:
+33(0)1-58-47-90-33 Solenne Anthonioz Tel: +33(0)1-58-47-90-27 Euro
RSCG Worldwide: Jonathan Sanchez Tel: +1-646-206-46-53 DATASOURCE:
Havas CONTACT: Contacts: Havas: Anne Marsan, Tel:
+33(0)1-58-47-90-33, , Solenne Anthonioz, Tel: +33(0)1-58-47-90-27,
; Euro RSCG Worldwide: Jonathan Sanchez, Tel: +1-646-206-46-53,
Copyright